Quick Answer
LB PHARMACEUTICALS INC reported Cash And Cash Equivalents At Carrying Value of $250.17 million for the year ending 2025.
- LB PHARMACEUTICALS INC showed an increase of +988.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from LB PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $250.17 million | Fiscal year 2024: $22.98 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: